
北美诊断成像市场预测至 2028 年 – COVID-19 影响和区域分析 – 按模态分类 [X 射线、计算机断层扫描、内窥镜检查、超声波、磁共振成像 (MRI)、核成像、乳房 X 线摄影等] 、应用(心脏病学、肿瘤学、神经病学、骨科、胃肠病学、妇产科等)和最终用户(医院和诊所、诊断成像中心、门诊手术中心等)
No. of Pages: 158 | Report Code: BMIRE00026315 | Category: Life Sciences
No. of Pages: 158 | Report Code: BMIRE00026315 | Category: Life Sciences
根据美国疾病控制与预防中心 (CDC) 的报告,十分之六的美国人至少患有一种慢性疾病,包括心脏病、中风、癌症和糖尿病。慢性病是北美死亡和残疾的主要原因,也是主要的医疗费用。据 CDC 统计,2020 年美国主要慢性病的年度医疗费用接近 4.1 万亿美元。诊断成像广泛应用于老年人群的慢性病,因为老年人更容易受到上述慢性病的影响。例如,JMIR Publications 透露,到 2050 年,全球 60 岁以上的人口预计将增加到 20 亿。因此,随着老龄化和慢性病的日益流行,必须注重医疗创新以改善健康服务。例如,在信息和通信技术 (ICT) 支持下的诊断成像创新已应用于多种环境,帮助个人更好地诊断、治疗和管理慢性病。此外,诊断成像中的信息通信技术干预措施还为与衰老和慢性病相关的一些挑战提供了解决方案。骨质疏松症是全球一个重大的健康问题,由于预期寿命的延长,造成严重的临床和经济负担。此外,骨质疏松症还会增加跌倒、骨折、住院和死亡的机会。计算机断层扫描 (CT)、磁共振成像 (MRI) 和超声成像等多种诊断成像技术可提供同一病理的不同方面的信息,以便在早期阶段检测骨质疏松症。例如,MRI 提供骨病理生理学各个方面的信息,其结果在早期诊断疾病、预防临床发病和后果方面发挥着重要作用。上述因素推动了整个诊断成像市场的发展。
借助新功能和技术,供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会在预测期内推动北美诊断成像市场实现大幅复合年增长率。
p>
北美诊断成像市场根据模式、应用、最终用户进行细分和国家。根据模式,市场分为 X 射线、计算机断层扫描、内窥镜检查、超声波、磁共振成像 (MRI)、核成像、乳房 X 线摄影等。 2021 年,计算机断层扫描领域占据最大的市场份额。预计在预测期内复合年增长率最高。根据应用,北美诊断成像市场分为心脏病学、肿瘤学、神经学、骨科、胃肠病学、妇产科等。心脏病学领域在 2021 年占据最大的市场份额,肿瘤学领域预计在预测期内复合年增长率最高。根据最终用户,市场分为医院和诊所、诊断成像中心、门诊手术中心(ASC)等。 2021年,医院和诊所领域占据最大的市场份额。然而,诊断成像中心领域预计在预测期内复合年增长率最高。根据国家/地区,北美诊断成像市场分为美国、加拿大和墨西哥。 2021年,美国占据最大的市场份额。预计在预测期内复合年增长率最高。
通用电气公司;西门子医疗;皇家飞利浦公司;卡尔史托斯公司两合公司;富士胶片控股公司;佳能公司;豪洛吉公司;锐珂健康公司;史赛克公司;和奥林巴斯公司是北美诊断成像市场的领先公司之一。
Strategic insights for North America Diagnostic Imaging involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 15,802.91 Million |
Market Size by 2028 | US$ 19,287.90 Million |
Global CAGR (2021 - 2028) | 6.2% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 方式
|
Regions and Countries Covered | 北美
|
Market leaders and key company profiles |
The regional scope of North America Diagnostic Imaging refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Diagnostic Imaging Market is valued at US$ 15,802.91 Million in 2021, it is projected to reach US$ 19,287.90 Million by 2028.
As per our report North America Diagnostic Imaging Market, the market size is valued at US$ 15,802.91 Million in 2021, projecting it to reach US$ 19,287.90 Million by 2028. This translates to a CAGR of approximately 6.2% during the forecast period.
The North America Diagnostic Imaging Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Diagnostic Imaging Market report:
The North America Diagnostic Imaging Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Diagnostic Imaging Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Diagnostic Imaging Market value chain can benefit from the information contained in a comprehensive market report.